Tilray Brands Posts Flat Revenue In Q1 2023

Tilray Brands (TSX: TLRY) this morning posted its first quarter financial results, with revenues staying flat on a quarter over quarter basis. The company meanwhile maintained that it retained the top spot within Canadian markets in terms of market share, with an 8.5% stake in the market.

Revenue for the quarter came in at $153.2 million, versus $153.3 million in the prior quarter, and $168.0 million in the year ago period. Of the revenue recorded, cannabis amounted to 38% of revenue at $61.6 million, while distribution revenue came in at $70.6 million, or 42%, beverage alcohol came in at $20.7 million, or 12%, and the wellness division came in at $13.7 million, or 8%. Gross profit meanwhile amounted to $48.6 million.

“Tilray Brands’ top and bottom-line results during the first quarter reflect successful realignment of the business to maximize revenue and market share gains across core business segments and geographies. Most notably, we are now the leader in net cannabis revenue worldwide [in federally legal markets], highlighted by medical cannabis leadership globally and adult-use cannabis market share primacy in Canada. These achievements affirm that, amid market disruption and macroeconomic challenges, we have leveraged our scale, marketing acumen and CPG expertise to deliver strong — and sustainable — top line growth,” commented Irwin Simon, CEO of Tilray.

While gross profit improved over the negative $6.7 million recorded in the fourth quarter, Tilray has yet to effectively grab control of its costs, with operating expenses totaling $69.8 million for the three month period, resulting in an operating loss of $21.2 million for the quarter. This was largely driven by general and administrative expenses of $40.5 million and amortization expenses of $24.4 million, and offset by transaction income of $12.8 million.

READ: President Biden Begins Process Of Reviewing Legality Of Cannabis At Federal Level

Overall, Tilray reported a net loss of $65.8 million, or $0.13 per share. Adjusted EBITDA was reported at $13.5 million. The company also confirmed guidance of $70 to $80 million in positive adjusted EBITDA for the fiscal year, and to be free cash flow positive in its operating business units this year. Free cash flow for the current quarter meanwhile was negative $47.8 million.

In terms of its balance sheet, the company saw its cash position improve to $490.6 million, while total assets overall grew to $910.9 million from $803.5 million. Total current liabilities meanwhile declined from $280.3 million to $273.3 million.

Tilray Brands last traded at $5.37 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

TomaGold Confirms Presence Of Berrigan Deep Zone Following Geophysics

Antimony Resources Reports Massive Stibnite Mineralization Over 25 Metres At Marcus (West) Zone

Related News

Cannabis Executives Complain Over Lack of Tax Reform in Canadian Budget… While Making Bank

Top executives from leading cannabis companies in Canada have voiced their dissatisfaction with the absence...

Thursday, April 18, 2024, 11:17:16 AM

Tilray Brands Q3 Earnings Analysis: Behind The CEO’s “Robust” Claims

“Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning...

Saturday, April 12, 2025, 03:28:00 PM

More Than 80% of Canada’s Cannabis CEOs at the Time of Adult-Use Legalization Have Left

Three years into adult-use legalization – fewer than 1 in 5 CEOs who were there...

Sunday, October 24, 2021, 09:00:00 AM

Palantir: The Future Of Organizational Data Science Because It Says So

Three weeks past its September 29, 2020 IPO, controversial data-science enterprise software company Palantir Technologies...

Wednesday, October 28, 2020, 04:07:00 PM

Tilray Obtains German Cannabis License Under New Regulations

Tilray Brands (TSX: TLRY) is reportedly in the process of expanding its operations in Germany,...

Monday, July 22, 2024, 09:31:50 AM